Prot #CA-170-101: A Phase 1, Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Orally Administered CA-170 in Patients with Advanced Tumors and Lymphomas

Project: Research project

Project Details

StatusFinished
Effective start/end date3/14/17 → 3/14/20

Funding

  • INC Research, LLC (Prot #CA-170-101)
  • Curis, Inc. (Prot #CA-170-101)